Author:
Mizoshita Tsutomu,Ando Masashi,Sagawa Hiroyuki,Mori Yoshinori,Katano Takahito,Ozeki Keiji,Tanida Satoshi,Okamoto Yasuyuki,Shimura Takaya,Kubota Eiji,Kataoka Hiromi,Kamiya Takeshi,Joh Takashi
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference22 articles.
1. Mizoshita T, Tanida S, Kusumoto S, et al. Adalimumab therapy following granulocyte and monocyte adsorptive apheresis in a patient with Crohn’s disease accompanied by chronic myeloid leukemia. Clin J Gastroenterol. 2012;5:302–6.
2. Van Deventer SJ. Tumour necrosis factor and Crohn’s disease. Gut. 1997;40:443–8.
3. Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial. Gastroenterology. 2006;130:323–33 (quiz 591).
4. Sugita A, Koganei K, Tatsumi K, et al. Management of rectal cancer including cancer in the anal fistula with Crohn’s disease. Nihon Shokakibyo Gakkai Zasshi. 2013;110:396–402.
5. Biancone L, Armuzzi A, Scribano ML, et al. Inflammatory bowel disease phenotype as risk factor for cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study. J Crohns Colitis. 2016;10:913–24.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献